CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.
CytoTronics has raised $13.5M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
CytoTronics's investors include Draper Associates, Legend Star, LYFE Capital, Anzu Partners, BoxOne Ventures.
CytoTronics is headquartered in Boston, United States.
CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.
CytoTronics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CytoTronics — Funding & Investors." VCBacked, September 5, 2024, https://www.vcbacked.co/company/cytotronics. Accessed July 19, 2026.
VCBacked. (2024). CytoTronics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cytotronics
{{cite web |title=CytoTronics — Funding & Investors |url=https://www.vcbacked.co/company/cytotronics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated